Cargando...

Recombinant immunotoxins and other therapies for relapsed/refractory hairy cell leukemia

Standard treatment for hairy cell leukemia (HCL) is markedly effective, but the constant decrease in disease-free survival, together with the presence of minimal residual disease (MRD), suggests that few if any are cured. HCL cells in MRD are always strongly CD20+ and CD22+, and also CD25 + unless t...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Leuk Lymphoma
Autores principales: KREITMAN, ROBERT J., ARONS, EVGENY, STETLER-STEVENSON, MARYALICE, FITZGERALD, DAVID J. P., WILSON, WYNDHAM H., PASTAN, IRA
Formato: Artigo
Lenguaje:Inglês
Publicado: 2011
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7435070/
https://ncbi.nlm.nih.gov/pubmed/21599609
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/10428194.2011.565843
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!